Abstract
The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Current Respiratory Medicine Reviews
Title: Exercise Limitation in Chronic Obstructive Pulmonary Disease
Volume: 4 Issue: 4
Author(s): Pierantonio Laveneziana, Karin Wadell, Katherine Webb and Denis E. O'Donnell
Affiliation:
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Abstract: The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Export Options
About this article
Cite this article as:
Laveneziana Pierantonio, Wadell Karin, Webb Katherine and O'Donnell E. Denis, Exercise Limitation in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263752
DOI https://dx.doi.org/10.2174/157339808786263752 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets Involvement of Cytokines and Inflammation in Catecholamine-Induced Pulmonary Injury in Rats
Vascular Disease Prevention (Discontinued) Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Current Medicinal Chemistry Clinical Applications of Creatine Supplementation on Paediatrics
Current Pharmaceutical Biotechnology Coronary Microcirculation in Heart Failure with Preserved Systolic Function
Current Pharmaceutical Design RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Expressions of eNOS3 and Ve-Cadherin in Microvascular Endothelium at 7-Day of Reperfused Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets Peripartum Cardiomyopathy: An Intriguing Challenge. Case Report with Literature Review
Current Cardiology Reviews Prognostic Implications of Genetics in Cardiovascular Disease
Current Pharmacogenomics Connexins, Diabetes and the Metabolic Syndrome
Current Protein & Peptide Science Family History and Preclinical Atherosclerosis
Current Hypertension Reviews The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Tityus serrulatus Scorpion Venom and Toxins: An Overview
Protein & Peptide Letters Integrins: Novel Therapeutic Targets for Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design The Impact of Dietary Habits and Nutritional Deficiencies in Urban African Patients Living with Heart Failure in Soweto, South Africa – A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Radionuclide PET and PET/CT in Coronary Artery Disease
Current Pharmaceutical Design Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Determinants of Left Ventricular Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)